Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Terumo Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
TRUMY
Over the counter
3841
www.terumo.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Terumo Corporation
Terumo Neuro Unveils New SOFIA™ 88 Catheter Data Demonstrating Strong Performance Compared to Other Super-Bore Catheters
- Jul 14th, 2025 7:00 am
Terumo seals US distribution deal with Caretaker Medical
- Jul 10th, 2025 8:49 am
Terumo Health Outcomes Announces Distribution Agreement for Caretaker Medical's VitalStream® Non-Invasive Hemodynamic Monitoring
- Jul 9th, 2025 7:00 am
Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System
- May 27th, 2025 11:40 am
Terumo Corp (TRUMF) Full Year 2025 Earnings Call Highlights: Record Sales and Strategic Growth ...
- May 16th, 2025 7:00 am
Terumo Neuro launches new neurovascular catheter in US
- May 15th, 2025 8:14 am
Expanding a Stroke Legacy: Terumo Neuro Announces US Commercial Availability of the SOFIA™ 88 Neurovascular Support Catheter
- May 13th, 2025 7:00 am
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer
- Apr 16th, 2025 1:00 pm
Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US
- Apr 16th, 2025 11:10 am
Terumo Neuro Receives FDA Approval for Carotid Stent System
- Apr 15th, 2025 7:00 am
Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment
- Mar 19th, 2025 7:00 am
J&J’s potential neurovascular exit: implications for market dynamics
- Feb 25th, 2025 4:38 am
Terumo Corp (TRUMF) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
- Feb 14th, 2025 4:00 am
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
- Feb 5th, 2025 7:00 am
Terumo Health Outcomes and Medis strike cardiovascular care partnership
- Dec 11th, 2024 6:44 am
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care
- Dec 10th, 2024 6:00 am
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
- Dec 3rd, 2024 6:00 am
Patients, Scientists Agree: Automated Red Blood Cell Exchange Enhances Quality of Life in Sickle Cell Disease Patients
- Nov 21st, 2024 4:15 am
Recent Price Trend in Terumo (TRUMY) is Your Friend, Here's Why
- Oct 30th, 2024 6:50 am
NAMSA and TERUMO Announce Strategic Outsourcing Partnership
- Oct 15th, 2024 11:01 am
Scroll